Geoffrey Liu

Has grant

Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Pan Canadian Lung Cancer Observational Study (PALEOS)

Open Date: 2021-04-01

Close Date: 2022-03-01

Grant: Close

Phase IB, Open-Label, Multi-Center Study to Determine the Efficacy and Safety of Durvalumab and/or Novel Oncology Therapies, With or Without Chemotherapy, for First- Line Stage IV Non-Small Cell Lung Cancer

Open Date: 2021-02-01

Close Date: 2021-04-01

Grant: Close

Breath analysis of patients diagnosed with lung cancer compared with healthy controls using infrared spectroscopy,

Open Date: 2021-02-01

Close Date: 2025-01-01

Grant: Close

LUNG cancer Earlier Detection to Intercept Cancerous-relapsing Tumors (Lung EDICT)

Open Date: 2021-01-01

Close Date: 2022-06-01

Grant: Close

Integrated use of wearable diagnostics in lung cancer

Open Date: 2021-01-01

Close Date: 2021-12-01

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Tracy Stockley

Department Head

University Health Network

CANADA

View details

Emma Vincent

University of Bristol

UNITED KINGDOM

View details

Janosch Ortmann

Professor

University of Quebec

CANADA

View details

Kimberley Burrows

University of Bristol

UNITED KINGDOM

View details

Rosalyn Juergens

CANADA

View details

Beata Swiatkowska

Assistant Professor

Medical University of Lodz

POLAND

View details

Colin Ross

Associate Professor

The University of British Columbia

CANADA

View details

Triantafillos Liloglou

Senior Lecturer

Edge Hill University

UNITED KINGDOM

View details

Andy Ness

University of Bristol

UNITED KINGDOM

View details

Mark Gormley

Consultant Senior Lecturer in Oral Surgery

University of Bristol

UNITED KINGDOM

View details

Bruce C. Carleton

CANADA

View details

Anke Maitland-van der Zee

Prof. Precision Medicine in Respiratory Disease

Amsterdam UMC Locatie AMC

NETHERLANDS

View details

Matthew Schabath

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Arvind Singh Mer

University of Ottawa

CANADA

View details

Susanne Arnold

University of Kentucky

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Geoffrey Liu

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study

Treatment patterns and outcomes in KRASG12C ‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study

On the informative value of community‐based indoor radon values in relation to lung cancer

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial.

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Outcomes with non-small cell lung cancer and brain-only metastasis.

Implementing routine collection of EQ-5D-5L in a breast cancer outpatient clinic.

Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer.

Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center Experience.

The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy.

Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization

Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.

Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.

Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study

Effects of Ethnicity on Outcomes of Patients With <i>EGFR</i> Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection.

A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.

Assessing therapy response in patient-derived xenografts.

The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.

Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.

Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality.

Collaborators (15)

Tracy Stockley

Emma Vincent

Janosch Ortmann

Kimberley Burrows

Rosalyn Juergens

Beata Swiatkowska

Colin Ross

Triantafillos Liloglou

Andy Ness

Mark Gormley

Bruce C. Carleton

Anke Maitland-van der Zee

Matthew Schabath

Arvind Singh Mer

Susanne Arnold

Make your next move.